GB Meka
Stocks to watch

CRL

Compare

CHARLES RIV LABS INTL INC · Healthcare

$295.01
▼ 0.3%Close 2026-09-30

Live intraday price

Compare with our price levels

T2326.46
T1306.13
E1269.62
E3203.14
SL192.97

Close 2026-09-30: $295.01 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 8.6% · 1 whale recently bought

1 month
▲ 2.3%
3 months
▲ 28.8%
1 year
▲ 100.7%
Analyst target
$301.29 +2.1%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$269.62 -8.6%
E2$218.39 -26.0%
E3$203.14 -31.1%
Targets
T1$306.13 3.8%
T2$326.46 10.7%
T3$346.80 17.6%
Stop-loss
SL$192.97 -34.6%
Whale cost ~$173.05 -41.3%

Risk : reward 1 : 2.6Moves ~$10.17 a day

⚖️ Positives and risks

✓ Positives (4)
  • ●1 whale bought or added last quarter
  • ●Long-term uptrend (above a rising MA200)
  • ●Beat the market (S&P 500) by +53% over 6 months
  • ●Most analysts rate it Buy
! Risks (4)
  • ●2 whales sold or trimmed: Lee Ainslie (sold out), Bridgewater (sold out)
  • ●Price is +41% above MA200 — already ran a lot
  • ●Revenue down -3% year over year
  • ●Company is still losing money (negative net margin)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-08-05Beat +10%

Actual EPS $3.02 · est. $2.74 · Before open

▲ 11.4%

Day 1

+11.9%

Next 20 days

2026-05-07Beat +5%

Actual EPS $2.06 · est. $1.95 · Before open

▼ 0.0%

Day 1

-0.2%

Next 20 days

2026-02-18In line +2%

Actual EPS $2.39 · est. $2.35 · Before open

▼ 0.3%

Day 1

-0.6%

Next 20 days

2025-11-05In line +4%

Actual EPS $2.43 · est. $2.34 · Before open

▼ 5.7%

Day 1

+9.7%

Next 20 days

2025-08-06Beat +22%

Actual EPS $3.12 · est. $2.55 · Before open

▼ 10.2%

Day 1

+8.0%

Next 20 days

2025-05-07Beat +13%

Actual EPS $2.34 · est. $2.07 · Before open

▲ 18.7%

Day 1

+3.1%

Next 20 days

2025-02-19Beat +5%

Actual EPS $2.66 · est. $2.53 · Before open

▲ 6.9%

Day 1

+5.4%

Next 20 days

2024-11-06Beat +7%

Actual EPS $2.59 · est. $2.42 · Before open

▲ 13.5%

Day 1

-10.6%

Next 20 days

Listen to the earnings call or read the full report on CRL's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$14.2B
Next earnings2026-11-04
P/E (price to earnings)-
Forward P/E (on expected earnings)23.2
Revenue growth (YoY)-2.7%
Earnings growth (YoY)-
Net profit margin-6.0%
ROE-7.5%
Debt to equity (D/E)105%
Dividend yield-
Analyst targets (high / low)$340.00 / $145.00
Number of analysts14
Trend and technical indicators
Trend short / mid / longUptrend ↗ · Uptrend ↗ · Uptrend ↗
RSI61
MA50 / MA200$273.49 / $209.04
Distance from MA200+41.1%
MACDPositive
1-year high / low$303.31 / $146.20
vs. S&P 500 (6 months)+53.2%
Volume vs. average0.80×